| INTRODUCTION
Currently, there is no cure for atopic dermatitis (AD), one of the most prevalent chronic diseases in childhood, affecting more than 20% of children.
1 Thus, there is a growing interest in primary prevention of AD. Perinatal probiotics reduce the risk of AD, and the combination of prenatal and post-natal supplementation appears to be most effective. [2] [3] [4] In the Probiotics in the Prevention of Allergy among Children in Trondheim (ProPACT) study, we observed that probiotics given to mothers from 36 weeks gestation to 3 months post-natally reduced the cumulative incidence of AD in the offspring by 40% at 2 years, 4 with a trend towards an ongoing benefit until 6 years. 5 However, the mechanism for this preventive effect is unclear.
The pathophysiology of AD involves barrier defects, environmental factors and immune dysfunction. 6, 7 The barrier defect is typically an early feature of AD which may be primary, but may also be secondary to the skin inflammation. [7] [8] [9] T helper (Th) cells are thought to be particularly important in the inflammation of AD, determining the degree and direction of the immune response. 6 Regulatory T cells (Tregs) are essential for limiting the excessive response. 10 Th cells are CD4+ T cells that exert their action mainly by activating and recruiting other cell types, and reduced Th1/Th2 ratio has been considered important for atopic diseases. 11 This skewing towards a Th2 response and low numbers of Tregs early in life are risk factors for later development of AD. 12, 13 More recently, other Th cell subsets like Th9, Th17 and Th22 have been shown to influence inflammation in AD. 11, [14] [15] [16] [17] Early intestinal microbiota is essential for normal maturation of the immune system and T cell balance, [18] [19] [20] and unfavourable composition of the microbiota is associated with T cell inflammation in AD. 21, 22 Probiotic bacteria have the ability to modify the Th balance through their effects on dendritic cells, [23] [24] [25] [26] but there are conflicting results on the distinct effects of probiotics on T cell subsets in children. Some studies have reported a skewing towards a Th1 profile with increase in interferon gamma (IFNc), while others have reported no effect on either the Th1/Th2 balance or Tregs. [27] [28] [29] [30] The effect of probiotics on Th9, Th17 and Th22 cells has not been studied previously.
Given the importance of T cell subsets in the pathogenesis of AD, we hypothesized that the risk reduction for AD observed in the ProPACT study may be due to an increase of regulatory and decrease of inflammatory Th cells in the children. 6 Our aim of this study was to examine whether the Th cells were affected by maternal probiotic supplementation and whether the preventive effect of probiotics on AD was mediated through an effect on Th cells.
2 | ME TH ODS
| Study population
Study subjects were recruited from the double-blinded randomized, placebo-controlled ProPACT study. 4 Briefly, 415 pregnant women from an unselected population were computer-randomized to ingest probiotic milk corresponding to a daily dose of 5x10 10 Trends were tested with Cuzick's nonparametric test for trends across ordered groups. Regression analysis was performed after BoxCox transformation to normality. Two-sided P-values <.05 were considered statistically significant.
We performed mediation analysis to estimate to what extent the effect of the probiotics on AD could be attributed to an effect on the Th cell subsets. Mediation, in statistical terms, is when some or all of the effects of the exposure on the outcome are caused via a third variable, the mediator. 33 If this is the case, the total effect can be partitioned into two parts: the direct effect and the indirect effect. The direct effect is the effect of the exposures not going through the mediator, and the indirect effect is the effect going through the mediator. Recent methods of mediation analysis use a counterfactual framework and allow for the natural variation of the level of the mediator between the subjects. 34 The natural direct effect (NDE) is then defined as the effect of the exposure on the outcome if the mediator is fixed to the level it would be in the absence of the exposure. The natural indirect effect (NIE) is defined as the effect on the outcome if the exposure is fixed to present, and the mediator is changed from the level it would take in the presence of exposure, to the level it takes in the absence of the exposure.
The total effect is then a combination of the NDE and the NIE. In this model, Total effect=NIE*NDE.
We performed causal mediation analysis using the user-written (Table S1 ).
| RESULTS
There were no significant differences in baseline characteristics of the pregnant women and their children between the two study groups (Table 1) . Consistent with the findings of the main study, there was a statistically significant reduction in the risk of AD following probiotic supplementation (Table 1 ). The distribution of baseline characteristics and outcome for the participants included in this study were similar to the participants of the original ProPACT study The proportion of Th cell subsets as percentages of the total Th cell population in the probiotic and placebo groups are shown in Table 2 . Th9 cells were not detectable in any samples, and Th22 There were no significant differences in the proportions of other Th subsets or the Th1/Th2 ratio between the probiotics and placebo groups (Table 2) , nor were the other Th subsets associated with the incidence, severity or age of debut of AD.
For the subgroup of participants with all the Th subsets analysed 
| DISCUSSION
In the present study, maternal probiotic supplementation led to a statistically significant lower proportion of Th22 cells in three- Proportions of T cell subsets are given as percentages of total Th cell population. Groups were compared using the Wilcoxon-Mann-Whitney U-test. Significant P-values in bold.
a Treg staining was performed on all samples (n=140). Cytokine staining for detection of the other Th subsets was performed on samples with adequate cell counts (n=77). Several studies have shown that probiotic intake during pregnancy and early infancy may act as a primary preventive measure against AD. [2] [3] [4] This preventive effect may be mediated through an early colonization of beneficial bacteria like LGG. The early gut microbiota is known to be important for shaping the immune system and establishing the Th cell balance. 18 Our group has previously shown that LGG bacteria ingested by mothers colonized their gut and that the LGG was transferred to the gut microbiota of the children. 37 Previous animal and in vitro studies suggest that immunomodulatory effects of probiotics are related to an increase of Tregs. 23 However, similar to previous clinical studies on the effects of probiotics in children, we did not find that maternal probiotics affected the Tregs. 29, 30 Likewise, effects on the Th1 and Th2 subsets have been hypothesized as possible mechanisms for the beneficial effects of probiotics on AD. [23] [24] [25] [26] Significant effects on the Th1 and Th2 cell proportions were not found in this study. Some previous intervention studies, but not all, have found that probiotics increase the Th1 cytokines. [27] [28] [29] [30] 38 These conflicting results may be due to differences in dose, duration or strain of probiotics as well as timing of blood sampling.
We found a significantly lower proportion of Th22 cells in the probiotic group. Furthermore, mediation analysis suggested that this effect may partly explain the preventive effect of probiotics on AD.
Taken together, our findings challenge the view that the mechanism of the preventive effect of maternal probiotics on AD is mediated by the Tregs or the Th1/Th2 axis. Instead, our results suggest that a reduction in Th22 cell proportion may play a role in the preventive effect of probiotics on AD.
Although this study cannot explain precisely how a reduced hand, there is evidence that IL-22 destabilizes the skin barrier in inflamed skin by inducing keratinocyte hyperplasia and suppressing the production of proteins crucial for epidermal integrity, such as keratin and filaggrin. 41, 42 Furthermore, IL-22 amplifies the inflammatory response by inducing keratinocyte release of proinflammatory proteins and chemokines. 40, 43 Thus, a lower Th22 cell proportion may block an early vicious cycle of inflammation and barrier defects and thereby prevent the development of symptomatic AD.
As some children with AD had high levels of Th22 despite being in the probiotic group, one can speculate whether the preventive effect of probiotics was restricted to specific populations. Our group has recently reported that the effect of probiotics in the prevention of AD can be dependent on the intrinsic microbiota. 44 High levels of Bifidobacterium dentium were associated with lack of the probiotic effect. Polymorphisms of pattern recognition receptors may also account for a differential effect of the probiotic bacteria. 45 LGG has been shown to modulate innate signalling pathways in a dose-dependent way 25 ; thus, the effect may be related to the abundance of
LGG. However, due to the sample size of our study, we could not perform a reliable subgroup analysis addressing this question. Future studies including cellular models, animal models and larger randomized studies would be needed to pursue these questions.
The major strength of this study is the prospective, randomized, controlled design within a general population with a clear clinical effect of the intervention. This offers the unique possibility to investigate mechanisms of the preventive effects of probiotics on AD.
Other strengths include using well-recognized criteria for AD, with clinical examinations of all the children.
There are some limitations to our study. A high proportion of the children were excluded from our study because of incomplete clinical data or missing samples. However, comparing baseline characteristics and outcome, the participants included in this study are comparable the original study population. 4 Furthermore, the randomized controlled design reduced the chance of any systematic bias between the placebo and probiotic groups; thus, the results should be valid.
Valid conclusions from mediation analysis require a correctly specified model as well as some strong assumptions. Firstly, it is assumed that the exposure (probiotic supplementation) preceded the mediator (Th22), which in turn preceded the outcome (AD). Considering the complex interaction between the epithelium and the Th subset, the reduction in Th22 cells may arguably reflect reduced skin inflammation that caused a reduction in both Th22 cell proportions and AD cases. However, the Th cell proportion was examined at 3 months of age, before most of the children developed AD. Furthermore, even in the subgroup of children that did not develop AD, lower Th22 cell proportions were found in the probiotic group compared to the control group. This supports the hypothesis that low Th22 cells was a preceding event and may be a mechanism for the protective effect of probiotics on AD.
Other assumptions of the mediation analysis revolve around the absence of unmeasured confounding between combinations of the exposure, mediator and outcome. 36 The randomized design meets the condition for mediation analysis that there are no unmeasured confounders of the relationship between the exposure and the outcome, or between the exposure and the mediator. However, addi- 
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